Intrinsiqs

Is Vaxcyte, Inc. overvalued?

Vaxcyte, Inc. (PCVX) — key valuation metrics and fundamentals.

No verdict
Price
$57.36
Fair value
Current P/E
Normal P/E
Market cap
$8.19B
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares PCVX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 29 Jun 2026.